BDPT Stock Overview
BioAdaptives, Inc. investigates, markets, and distributes natural plant and algal-based products for humans and animals.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
BioAdaptives, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0004 |
| 52 Week High | US$0.006 |
| 52 Week Low | US$0.00025 |
| Beta | 0.24 |
| 1 Month Change | 0% |
| 3 Month Change | -55.56% |
| 1 Year Change | -42.86% |
| 3 Year Change | -98.57% |
| 5 Year Change | -99.78% |
| Change since IPO | -99.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| BDPT | US Personal Products | US Market | |
|---|---|---|---|
| 7D | -20.0% | 5.4% | 1.2% |
| 1Y | -42.9% | -25.4% | 24.7% |
Return vs Industry: BDPT underperformed the US Personal Products industry which returned -25.4% over the past year.
Return vs Market: BDPT underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| BDPT volatility | |
|---|---|
| BDPT Average Weekly Movement | 37.4% |
| Personal Products Industry Average Movement | 8.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BDPT's share price has been volatile over the past 3 months.
Volatility Over Time: BDPT's weekly volatility has decreased from 43% to 37% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 5 | Ted Jacobs | www.shopbioadaptives.com |
BioAdaptives, Inc. investigates, markets, and distributes natural plant and algal-based products for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers PluriPain, a fast acting long lasting natural pain relief formulation; PrimiLungs; MindNMemory, a nootropic formulation that enhances memory, focus, mental clarity, and endurance; PrimiSleep, a natural soporific that aids relaxation and sleep quality; Cell Rejuven that increases energy and mobility and resistance to stress, activates primitive cells, enhances wound healing, and promotes hair and nail growth; and ProteinNMore, which builds lean bulk muscle, and promotes muscle contractility and strength, as well as helps in improving blood flow.
BioAdaptives, Inc. Fundamentals Summary
| BDPT fundamental statistics | |
|---|---|
| Market cap | US$492.69k |
| Earnings (TTM) | -US$712.47k |
| Revenue (TTM) | US$28.57k |
17.2x
P/S Ratio-0.7x
P/E RatioIs BDPT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BDPT income statement (TTM) | |
|---|---|
| Revenue | US$28.57k |
| Cost of Revenue | US$17.75k |
| Gross Profit | US$10.82k |
| Other Expenses | US$723.29k |
| Earnings | -US$712.47k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00058 |
| Gross Margin | 37.88% |
| Net Profit Margin | -2,494.19% |
| Debt/Equity Ratio | -20.0% |
How did BDPT perform over the long term?
See historical performance and comparison